Sleep Medicine Reviews
Volume 13, Issue 6 , Pages 437-444 , December 2009

Obstructive sleep apnea and depression

  • Melanie Harris

      Affiliations

    • Australasian Sleep Trials Network (funded by the National Health and Medical Research Council), c/o Adelaide Institute for Sleep Health, Flinders University, Adelaide, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 8 8404 2323; fax: +61 8 8404 2101.
    • ,
  • Nick Glozier

      Affiliations

    • The George Institute for International Health, Sydney University, Sydney, Australia
    • Tel.: +61 2 9993 4575; fax: +61 2 9657 0301.
    • ,
  • Rajeev Ratnavadivel

      Affiliations

    • Adelaide Institute for Sleep Health, Flinders University, Adelaide, Australia
    • Tel.: +61 8 8276 9666; fax: +61 8 8277 6890.
    • ,
  • Ronald R. Grunstein

      Affiliations

    • Woolcock Institute of Medical Research and National Health and Medical Research Council Centre for Respiratory and Sleep Medicine, University of Sydney, Australia
    • Tel.: +61 2 9515 8630; fax: +61 2 9515 7070.

References∗ 

  1. Lin EHB, Katon W, Rutter C, Simon GE, Ludman JE, Von Korff M, et al. Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med. 2006;4:46–53
  2. Coyne JC, Thompson R, Klinkman MS, Nease DE. Emotional disorders in primary care. J Consult Clin Psychol. 2002;70:798–809
  3. Sforza E, de Saint Hilaire Z, Pelissolo A, Rochat T, Ibanez V. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med. 2002;3:139–145
  4. Grayson DA, Mackinnon A, Jorm AF, Creasey H, Broe GA. Item bias in the center for epidemiologic studies depression scale: effects of physical disorders and disability in an elderly community sample. J Gerontol B Psychol Sci Soc Sci. 2000;55:P273–P282
  5. Sodeman E, Lisspers J. Diagnosing depression in patients with physical diseases using the beck depression inventory (BDI). Cogn Behav Ther. 1997;26:102–112
  6. Sanchez AI, Buela-Casal G, Bermudez MP, Casas-Maldonado F. The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin Neurosci. Dec 2001;vol. 55(6):641–646
  7. Aloia MS, Arnedt JT, Smith L, Skrekas J, Stanchina M, Millman RP. Examining the construct of depression in obstructive sleep apnea syndrome. Sleep Med. 2005;6:115–121
  8. Andrews JG, Oei TPS. The roles of depression and anxiety in the understanding and treatment of obstructive sleep apnea syndrome. Clin Psychol Rev. 2004;24:1031–1049
  9. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med. 2006;166:1709–1715
  10. Hashmi AM, Giray N, Hirshkowitz M. Sleep-related breathing disorders and mood disorders. Sleep Med Clin. 2006;1:513–517
  11. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77
  12. Kapur VK, Baldwin CM, Resnick HE, Gottlieb DJ, Nieto FJ. Sleepiness in patients with moderate to severe sleep-disordered breathing. Sleep. 2005;28:472–477
  13. Gottlieb DJ, Whitney CW, Bonekat WH, Iber C, James GD, Lebowitz M, et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med. 1999;159:502–507
  14. Kroenke K, Price RK. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med. 1993;153:2474–2480
  15. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab. 2005;90:4510–4515
  16. Bardwell WA, Ancoli-Israel S, Dimsdale JE. Comparison of the effects of depressive symptoms and apnea severity on fatigue in patients with obstructive sleep apnea: a replication study. J Affect Disord. Jan 2007;vol. 97(1–3):181–186
  17. Hayashida K, Inoue Y, Chiba S, Yagi T, Urashima M, Honda Y, et al. Factors influencing subjective sleepiness in patients with obstructive sleep apnea syndrome. Psychiatry Clin Neurosci. 2007;61:558–563
  18. Kjelsberg FN, Ruud EA, Stavem K. Predictors of symptoms of anxiety and depression in obstructive sleep apnea. Sleep Med. 2005;6:341–346
  19. Santamaria J, Iranzo A, Ma Montserrat J, de Pablo J. Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment. Sleep Med Rev. 2007;11:195–207
  20. Cooke L, Wardle J. Depression and obesity. In:  Steptoe A editors. Depression and physical illness. Cambridge: Cambridge University Press; 2006;p. 238–261
  21. Bardwell WA, Berry CC, Ancoli-Israel S, Dimsdale JE. Psychological correlates of sleep apnea. J Psychosom Res. 1999;47:583–596
  22. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217–1239
  23. Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry. 2003;64:1195–1200
  24. Akhtar-Danesh N, Landeen J. Relation between depression and sociodemographic factors. Int J Ment Health Syst. 2007;1–9
  25. Benton T, Staab J, Evans DL. Medical co-morbidity in depressive disorders. Ann Clin Psychiatry. 2007;19:289–303
  26. Izumi I, Nasermoaddeli A, Sekine M, Kagamimori S. Effect of moderate alcohol intake on nocturnal sleep respiratory parameters in healthy middle-aged men. Environ Health Prev Med. 2005;10:16–20
  27. Moreno CRC, Carvalho FA, Lorenzi C, Matuzaki LS, Prezotti S, Bighetti P, et al. High risk for obstructive sleep apnea in truck drivers estimated by the Berlin questionnaire: prevalence and associated factors. Chronobiol Int. 2004;21:871–879
  28. Nerfeldt P, Graf P, Borg S, Friberg D. Prevalence of high alcohol and benzodiazepine consumption in sleep apnea patients studied with blood and urine tests. Acta Otolaryngol (Stockh). 2004;124:1187–1190
  29. Daley A. Exercise and depression: a review of reviews. J Clin Psychol Med Settings. 2008;15:140–147
  30. Quan SF, O'Connor GT, Quan JS, Redline S, Resnick HE, Shahar E, et al. Association of physical activity with sleep-disordered breathing. Sleep Breath. 2007;11:149–157
  31. Wahner-Roedler DL, Olson EJ, Narayanan S, Sood R, Hanson AC, Loehrer LL, et al. Gender-specific differences in a patient population with obstructive sleep apnea-hypopnea syndrome. Gend Med. 2007;4:329–338
  32. McCall WV, Harding D, O'Donovan C. Correlates of depressive symptoms in patients with obstructive sleep apnea. J Clin Sleep Med. 2006;2:424–426
  33. Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep. 2005;28:309–314
  34. Piccinelli M, Wilkinson G. Gender differences in depression. Critical review. Br J Psychiatry. 2000;177:486–492
  35. Rotenberg VS, Indursky P, Kayumov L, Sirota P, Melamed Y. The relationship between subjective sleep estimation and objective sleep variables in depressed patients. Int J Psychophysiol. 2000;37:291–297
  36. Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep. 2005;28:1405–1411
  37. Sivertsen B, Overland S, Glozier N, Bjorvatn B, Maeland JG, Mykletun A. The effect of OSAS on sick leave and work disability. Eur Respir J. 2008;32:1497–1503
  38. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–226
  39. Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med. 2003;4:343–345
  40. Saunamaki T, Jehkonen M. Depression and anxiety in obstructive sleep apnea syndrome: a review. Acta Neurol Scand. 2007;116:277–288
  41. Kripke DF, Ancoli-Israel S, Klauber MR, Wingard DL, Mason WJ, Mullaney DJ. Prevalence of sleep-disordered breathing in ages 40–64 years: a population-based survey. Sleep. 1997;20:65–76
  42. Pillar G, Lavie P. Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest. 1998;114:697–703
  43. Glebocka A, Kossowska A, Bednarek M. Obstructive sleep apnea and the quality of life. J Physiol Pharmacol. 2006;57(Suppl. 4):111–117
  44. Lee C, Morton CC. Structural genomic variation and personalized medicine. N Engl J Med. 2008;358:740–741
  45. Enright PL, Newman AB, Wahl PW, Manolio TA, Haponik EF, Boyle PJ. Prevalence and correlates of snoring and observed apneas in 5201 older adults. Sleep. 1996;19:531–538
  46. Smith R, Ronald J, Delaive K, Walld R, Manfreda J, Kryger MH. What are obstructive sleep apnea patients being treated for prior to this diagnosis?. Chest. 2002;121:164–172
  47. Farney RJ, Lugo A, Jensen RL, Walker JM, Cloward TV. Simultaneous use of antidepressant and antihypertensive medications increases likelihood of diagnosis of obstructive sleep apnea syndrome. Chest. 2004;125:1279–1285
  48. Means MK, Lichstein KL, Edinger JD, Taylor DJ, Durrence HH, Husain AM, et al. Changes in depressive symptoms after continuous positive airway pressure treatment for obstructive sleep apnea. Sleep Breath. 2003;7:31–42
  49. Schwartz DJ, Kohler WC, Karatinos G. Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. Chest. 2005;128:1304–1309
  50. Kawahara S, Akashiba T, Akahoshi T, Horie T. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med. 2005;44:422–427
  51. Munoz A, Mayoralas LR, Barbe F, Pericas J, Agusti AGN. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J. 2000;15:676–681
  52. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;e45
  53. Barnes M, Houston D, Worsnop CJ, Neill AM, Mykytyn IJ, Kay A, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165:773–780
  54. Haensel A, Norman D, Natarajan L, Bardwell WA, Ancoli-Israel S, Dimsdale JE. Effect of a 2 week CPAP treatment on mood states in patients with obstructive sleep apnea: a double-blind trial. Sleep Breath. 2007;11:239–244
  55. Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;CD001106
  56. Henke KG, Grady JJ, Kuna ST. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2001;163:911–917
  57. Bardwell WA, Norman D, Ancoli-Israel S, Loredo JS, Lowery A, Lim W, et al. Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea: a randomized placebo-controlled study. Behav Sleep Med. 2007;5:21–38
  58. Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev. 2006;CD004435
  59. Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170:656–664
  60. Naismith SL, Winter VR, Hickie IB, Cistulli PA. Effect of oral appliance therapy on neurobehavioral functioning in obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med. 2005;1:374–380
  61. Katon W, Lin EHB, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147–155
  62. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58:175–189
  63. Rosenberg RS. Depression in the sleep center: are we treating the whole patient?. Sleep Med. 2003;4:269
  64. Simon GE, Katon WJ, Lin EHB, Rutter C, Manning WG, Von Korff M, et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry. 2007;64:65–72
  65. Unutzer J, Katon W, Callahan CM, Williams JW, Hunkeler E, Harpole L, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836–2845
  66. de Jonge P, Honig A, van Melle JP, Schene AH, Kuyper AM, Tulner D, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry. 2007;164:1371–1378
  67. Riemann D, Berger M, Voderholzer U. Sleep and depression – results from psychobiological studies: an overview. Biol Psychol. 2001;57:67–103
  68. Winokur A, Gary KA, Rodner S, Rae-Red C, Fernando AT, Szuba MP. Depression, sleep physiology, and antidepressant drugs. Depress Anxiety. 2001;14:19–28
  69. Smith SS, Dingwall K, Jorgenson G, Douglas J. Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea. J Clin Sleep Med. 2006;2:156–162
  70. Akashiba T, Kawahara S, Akahoshi T, Omori C, Saito O, Majima T, et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest. 2002;122:861–865
  71. Wells RD, Freedland KE, Carney RM, Duntley SP, Stepanski EJ. Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure. Psychosom Med. 2007;69:449–454
  72. Yue W, Hao W, Liu P, Liu T, Ni M, Guo Q. A case–control study on psychological symptoms in sleep apnea-hypopnea syndrome. Can J Psychiatry. 2003;48:318–323
  73. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85:1151–1158
  74. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997;82:1313–1316
  75. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab. 2004;89:4409–4413
  76. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21:374–383
  77. Jans LAW, Riedel WJ, Markus CR, Blokland A. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry. 2007;12:522–543
  78. Fenik P, Veasey SC. Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus. Am J Respir Crit Care Med. 2003;167:563–569
  79. Reimer MA, Flemons WW. Quality of life in sleep disorders. Sleep Med Rev. 2003;7:335–349
  80. Mrazek DA, Smoller JW, de Leon J, Ginsberg DL. Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. CNS Spectr. Mar 2006;vol. 11(3):1–2

PII: S1087-0792(09)00039-2

doi: 10.1016/j.smrv.2009.04.001

Sleep Medicine Reviews
Volume 13, Issue 6 , Pages 437-444 , December 2009

Article Tools

* Image Usage & Resolution